These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34281620)

  • 1. ACER3-related leukoencephalopathy: expanding the clinical and imaging findings spectrum due to novel variants.
    Dehnavi AZ; Heidari E; Rasulinezhad M; Heidari M; Ashrafi MR; Hosseini MM; Sadeghzadeh F; Fallah MS; Rostampour N; Bahraini A; Garshasbi M; Tavasoli AR
    Hum Genomics; 2021 Jul; 15(1):45. PubMed ID: 34281620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of alkaline ceramidase 3 with infancy-onset progressive leukoencephalopathy: a second case report.
    Kilic H; Dogan M; Sahin S; Saltik S; Yalcinkaya C
    Acta Neurol Belg; 2021 Dec; 121(6):1867-1870. PubMed ID: 32816236
    [No Abstract]   [Full Text] [Related]  

  • 3. Deficiency of the alkaline ceramidase ACER3 manifests in early childhood by progressive leukodystrophy.
    Edvardson S; Yi JK; Jalas C; Xu R; Webb BD; Snider J; Fedick A; Kleinman E; Treff NR; Mao C; Elpeleg O
    J Med Genet; 2016 Jun; 53(6):389-96. PubMed ID: 26792856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic characterization of leukoencephalopathies in adults.
    Lynch DS; Rodrigues Brandão de Paiva A; Zhang WJ; Bugiardini E; Freua F; Tavares Lucato L; Macedo-Souza LI; Lakshmanan R; Kinsella JA; Merwick A; Rossor AM; Bajaj N; Herron B; McMonagle P; Morrison PJ; Hughes D; Pittman A; Laurà M; Reilly MM; Warren JD; Mummery CJ; Schott JM; Adams M; Fox NC; Murphy E; Davagnanam I; Kok F; Chataway J; Houlden H
    Brain; 2017 May; 140(5):1204-1211. PubMed ID: 28334938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing of leukodystrophies unraveling extensive heterogeneity in a large cohort and report of five common diseases and 38 novel variants.
    Mahdieh N; Soveizi M; Tavasoli AR; Rabbani A; Ashrafi MR; Kohlschütter A; Rabbani B
    Sci Rep; 2021 Feb; 11(1):3231. PubMed ID: 33547378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukodystrophies and Genetic Leukoencephalopathies in Children Specified by Exome Sequencing in an Expanded Gene Panel.
    Parayil Sankaran B; Nagappa M; Chiplunkar S; Kothari S; Govindaraj P; Sinha S; Taly AB
    J Child Neurol; 2020 Jun; 35(7):433-441. PubMed ID: 32180488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic Spectrum and Natural History of Cavitating Leukoencephalopathies in Childhood.
    Zhang J; Liu M; Zhang Z; Zhou L; Kong W; Jiang Y; Wang J; Xiao J; Wu Y
    Pediatr Neurol; 2019 May; 94():38-47. PubMed ID: 30770271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole exome sequencing in patients with white matter abnormalities.
    Vanderver A; Simons C; Helman G; Crawford J; Wolf NI; Bernard G; Pizzino A; Schmidt JL; Takanohashi A; Miller D; Khouzam A; Rajan V; Ramos E; Chowdhury S; Hambuch T; Ru K; Baillie GJ; Grimmond SM; Caldovic L; Devaney J; Bloom M; Evans SH; Murphy JLP; McNeill N; Fogel BL; ; Schiffmann R; van der Knaap MS; Taft RJ
    Ann Neurol; 2016 Jun; 79(6):1031-1037. PubMed ID: 27159321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical exome sequencing identifies a novel TUBB4A mutation in a child with static hypomyelinating leukodystrophy.
    Purnell SM; Bleyl SB; Bonkowsky JL
    Pediatr Neurol; 2014 Jun; 50(6):608-11. PubMed ID: 24742798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the phenotypic spectrum of TUBB4A-associated hypomyelinating leukoencephalopathies.
    Miyatake S; Osaka H; Shiina M; Sasaki M; Takanashi J; Haginoya K; Wada T; Morimoto M; Ando N; Ikuta Y; Nakashima M; Tsurusaki Y; Miyake N; Ogata K; Matsumoto N; Saitsu H
    Neurology; 2014 Jun; 82(24):2230-7. PubMed ID: 24850488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomyelination with atrophy of the basal ganglia and cerebellum: further delineation of the phenotype and genotype-phenotype correlation.
    Hamilton EM; Polder E; Vanderver A; Naidu S; Schiffmann R; Fisher K; Raguž AB; Blumkin L; ; van Berkel CG; Waisfisz Q; Simons C; Taft RJ; Abbink TE; Wolf NI; van der Knaap MS
    Brain; 2014 Jul; 137(Pt 7):1921-30. PubMed ID: 24785942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New clinical characteristics and novel pathogenic variants of patients with hereditary leukodystrophies.
    Xie JJ; Ni W; Wei Q; Ma H; Bai G; Shen Y; Wu ZY
    CNS Neurosci Ther; 2020 May; 26(5):567-575. PubMed ID: 31885218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological, clinical, and genetic characteristics of paediatric genetic white matter disorders in Northern Finland.
    Knuutinen OA; Oikarainen JH; Suo-Palosaari MH; Kangas SM; Rahikkala EJ; Pokka TM; Moilanen JS; Hinttala RML; Vieira PM; Uusimaa JM
    Dev Med Child Neurol; 2021 Sep; 63(9):1066-1074. PubMed ID: 33948933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.
    Ashrafi MR; Amanat M; Garshasbi M; Kameli R; Nilipour Y; Heidari M; Rezaei Z; Tavasoli AR
    Expert Rev Neurother; 2020 Jan; 20(1):65-84. PubMed ID: 31829048
    [No Abstract]   [Full Text] [Related]  

  • 15. Biallelic mutations in the homeodomain of NKX6-2 underlie a severe hypomyelinating leukodystrophy.
    Dorboz I; Aiello C; Simons C; Stone RT; Niceta M; Elmaleh M; Abuawad M; Doummar D; Bruselles A; Wolf NI; Travaglini L; Boespflug-Tanguy O; Tartaglia M; Vanderver A; Rodriguez D; Bertini E
    Brain; 2017 Oct; 140(10):2550-2556. PubMed ID: 28969374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic disorders with central nervous system white matter abnormalities: An update.
    Shukla A; Kaur P; Narayanan DL; do Rosario MC; Kadavigere R; Girisha KM
    Clin Genet; 2021 Jan; 99(1):119-132. PubMed ID: 33047326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brother and sister with intellectual disability and characteristic neuroimaging findings.
    Hermens M; van der Knaap MS; Kamsteeg EJ; Willemsen MA
    Eur J Paediatr Neurol; 2018 Sep; 22(5):866-869. PubMed ID: 29970281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis.
    Hu W; Xu R; Sun W; Szulc ZM; Bielawski J; Obeid LM; Mao C
    J Biol Chem; 2010 Mar; 285(11):7964-76. PubMed ID: 20068046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel (ovario) leukodystrophy related to AARS2 mutations.
    Dallabona C; Diodato D; Kevelam SH; Haack TB; Wong LJ; Salomons GS; Baruffini E; Melchionda L; Mariotti C; Strom TM; Meitinger T; Prokisch H; Chapman K; Colley A; Rocha H; Ounap K; Schiffmann R; Salsano E; Savoiardo M; Hamilton EM; Abbink TE; Wolf NI; Ferrero I; Lamperti C; Zeviani M; Vanderver A; Ghezzi D; van der Knaap MS
    Neurology; 2014 Jun; 82(23):2063-71. PubMed ID: 24808023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkaline ceramidase catalyzes the hydrolysis of ceramides via a catalytic mechanism shared by Zn2+-dependent amidases.
    Yi JK; Xu R; Obeid LM; Hannun YA; Airola MV; Mao C
    PLoS One; 2022; 17(9):e0271540. PubMed ID: 36048828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.